Ezy medical research

Miami, Florida 33175

0 studies enrolling now · 11 studies all time

What they study most

Alzheimer Disease, Anhedonia, Atherosclerotic Cardiovascular Disease, Crohn's Disease, Depressive Disorder, Major, Diabetes Type 2, Mild Cognitive Impairment, Mild Dementia, Parkinson Disease, Systemic Lupus Erythematosus

Studies at this site

• A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) — Stopped early
• Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1) — Completed
• A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy — Completed
• A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Running, not enrolling
• A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) — Running, not enrolling
• A IMMA Master Protocol: A Study of LY3361237 in Participants With at Least Moderately Active Systemic Lupus Erythematosus — Stopped early
• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed
• Optina Diagnostics' Cerebral ß-Amyloid Status (CAS) Test — Completed
• Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease — Running, not enrolling
• Eye to Brain Connection — Completed
• NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa — Completed